Poxel Reports Revenue for the Full Year 2024 and Provides an Update on its Financial Position and Outlook Feb 19, 2025
Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast Jan 31, 2025
Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment Jan 20, 2025
Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan Jan 20, 2025
Poxel Reports Financial Results for First Half 2024 and Provides an Update on its Financial Position and Outlook Dec 9, 2024
